Open access
Aug 2026
Epigenetic Reactivation of TNFRSF19 Suppresses Mitophagy and Sensitizes Triple‐Negative Breast Cancer to Doxorubicin
Findings establish TNFRSF19 as a critical epigenetic regulator of mitophagy, highlighting its potential as a predictive biomarker for doxorubicin response and a therapeutic target for sensitizing TNBC to doxorubicin.
Shiyang Liu, Chen-Guang Liu, Wei-Hong Zheng et al.
· Advancement of science · 1 citation